Etude Clinique de Phase I de Radiosensibilisation de métastases cérébrales Par Nanoparticules de Gadolinium
Latest Information Update: 19 Mar 2021
At a glance
- Drugs Gadolinium chelated polysiloxane based nanoparticle (Primary) ; Gadoterate-meglumine
- Indications Brain metastases
- Focus Adverse reactions; First in man
- Acronyms NANO-RAD; NANORAD1
- 19 Mar 2021 Results published in the health and medicine journal.
- 17 Mar 2021 New trial record